It is the imbalance of this negative feedback circle that leads to the malignant progression of glioma, which undoubtedly highlights the critical role of RIPK2-mediated NF-κB hyperactivation in pathogenesis. This evidence concerns the gene NFKB1 and central nervous system cancer.